(Q46276232)

English

Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinoma

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

Enhancement of the anti-tumor immune response using a combination of interferon-gamma and B7 expression in an experimental mammary carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

author name string

A A Hurwitz

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

S E Townsend

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

T F Yu

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

J A Wallin

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

J P Allison

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

77

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

107-113

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

CD28-B7 interactions in T-cell activation.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Manipulation of costimulatory signals to enhance antitumor T-cell responses.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Interferon gamma: a master key in the immune system

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Interferon--a major regulator of natural killer cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

A reassessment of the role of B7-1 expression in tumor rejection.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C107%3A%3AAID-IJC17%3E3.0.CO%3B2-B

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19980703)77:1<107::AID-IJC17>3.0.CO;2-B

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/9639401

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46276232&oldid=2102979269"